Updates from The Motley Fool

Latest updates on OPEXA THERAPEUTICS, INC. from Fool.com.

Stock Charting

OPXA vs. SPY | 2 Year Performance
OPXA 1-Day Stock Chart
OPXA 5-Day Stock Chart
OPXA 1-Month Stock Chart
OPXA 3-Month Stock Chart
OPXA 6-Month Stock Chart
OPXA 1-Year Stock Chart
OPXA 2-Year Stock Chart
OPXA 5-Year Stock Chart
View Interactive OPXA Charts
Sponsored by

Key Data Points

Primary metrics and data points about OPEXA THERAPEUTICS, INC..
Current Price: $2.35
Prev Close: $2.27
Open: $2.25
Bid: $2.33
Ask: $2.36
Day's Range: $2.20 - $2.37
52wk Range: $1.69 - $5.84
Volume: 13,913
Avg Vol 33,350
Market Cap: $16.13M
P/E (ttm): -1.11
EPS (ttm): -$2.05
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about OPEXA THERAPEUTICS, INC..
CAPS Rating 2 out of 5
37 Outperform
9 Underperform
CAPS All Stars
9 Outperform
4 Underperform

How do you think OPEXA THERAPEUTICS, INC. will perform against the market?

You pick for OPEXA THERAPEUTICS, INC. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Neil K. Warma, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for OPEXA THERAPEUTICS, INC..

A biopharmaceutical company developing autologous cellular therapies to treat several major illnesses, including multiple sclerosis, rheumatoid arthritis, diabetes, and cardiovascular disease.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers